- Home
- VIAV vs BCRX Comparison
VIAV vs BCRX Comparison
Compare VIAV & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIAV
- BCRX
- Stock Information
- Founded
- VIAV 1923
- BCRX 1986
- Country
- VIAV United States
- BCRX United States
- Employees
- VIAV N/A
- BCRX N/A
- Industry
- VIAV Semiconductors
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VIAV Technology
- BCRX Health Care
- Exchange
- VIAV Nasdaq
- BCRX Nasdaq
- Market Cap
- VIAV 2.0B
- BCRX 1.7B
- IPO Year
- VIAV 1993
- BCRX 1994
- Fundamental
- Price
- VIAV $9.19
- BCRX $9.97
- Analyst Decision
- VIAV Buy
- BCRX Buy
- Analyst Count
- VIAV 8
- BCRX 8
- Target Price
- VIAV $12.69
- BCRX $16.75
- AVG Volume (30 Days)
- VIAV 2.5M
- BCRX 5.9M
- Earning Date
- VIAV 05-01-2025
- BCRX 05-05-2025
- Dividend Yield
- VIAV N/A
- BCRX N/A
- EPS Growth
- VIAV N/A
- BCRX N/A
- EPS
- VIAV 0.02
- BCRX N/A
- Revenue
- VIAV $1,045,800,000.00
- BCRX $503,485,000.00
- Revenue This Year
- VIAV $10.56
- BCRX $27.64
- Revenue Next Year
- VIAV $7.78
- BCRX $13.42
- P/E Ratio
- VIAV $431.62
- BCRX N/A
- Revenue Growth
- VIAV 3.34
- BCRX 41.67
- 52 Week Low
- VIAV $6.60
- BCRX $5.06
- 52 Week High
- VIAV $12.91
- BCRX $11.11
- Technical
- Relative Strength Index (RSI)
- VIAV 34.89
- BCRX 65.89
- Support Level
- VIAV $8.75
- BCRX $9.83
- Resistance Level
- VIAV $9.31
- BCRX $11.11
- Average True Range (ATR)
- VIAV 0.37
- BCRX 0.51
- MACD
- VIAV -0.08
- BCRX 0.20
- Stochastic Oscillator
- VIAV 38.38
- BCRX 68.33
About VIAV Viavi Solutions Inc.
Viavi Solutions Inc. is a global provider of network test, monitoring and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of revenue from the United States.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.